Managing Your AAT Deficient Patient
Help patients with alpha1-antitrypsin (AAT) deficiency* learn to live with a chronic condition by providing them with tools and resources that may help them stay as healthy as possible.
*Also known as Alpha-1, AAT deficiency, AATD, A1-PI deficiency, alpha-1 antiprotease deficiency, A1AD, or hereditary or genetic emphysema.
Alpha1Health.com is here to help you manage many aspects of your AAT deficient patients. We invite you to visit other sections of our website to learn more.
Here are some good starting points:
ARALAST [Alpha1-Proteinase Inhibitor (Human)] is indicated for chronic augmentation therapy in patients having congenital deficiency of A1-PI with clinically evident emphysema. ARALAST is not indicated as therapy for lung disease patients in whom congenital A1-PI deficiency has not been established.
Please review the Important Safety Information and the Full Prescribing Information
| To view PDF, you will need Adobe® Acrobat® Reader® software. |

